Drug Profile
RJR 2557
Latest Information Update: 25 Jun 2001
Price :
$50
*
At a glance
- Originator R. J. Reynolds Tobacco Company
- Class Neuroprotectants; Nootropics; Pyridines; Small molecules; Solanaceous alkaloids
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 25 Jun 2001 No-Development-Reported for Cognition disorders in USA (Unknown route)
- 01 Apr 1998 Preclinical development for Cognition disorders in USA (Unknown route)